Editorial Alimentary pharmacology & therapeutics. 2025 Apr 8. doi: 10.1111/apt.70143 Q16.62024
Editorial: How to Interpret Clinical Impact of Viral Replication Activity for Postoperative Recurrence of HBV-Related HCC-Authors' Reply
编辑来信:HBV相关肝细胞癌术后复发的病毒复制活性临床意义如何解读-作者回信 翻译改进
作者单位 +展开
作者单位
DOI: 10.1111/apt.70143 PMID: 40197655
摘要 中英对照阅读
相关内容
-
Editorial: How to Interpret Clinical Impact of Viral Replication Activity for Postoperative Recurrence of HBV-Related HCC
组稿:HBV相关HCC术后复发的病毒活性临床意义如何解读?
Alimentary pharmacology & therapeutics. 2025 Apr 8.
-
Association Between Viral Replication Activity and Postoperative Recurrence of HBV-Related Hepatocellular Carcinoma
病毒复制活性与乙肝相关肝细胞癌术后复发的相关性研究
Alimentary pharmacology & therapeutics. 2025 Mar 16.
-
Letter: Association Between Viral Replication Activity and Postoperative Recurrence of HBV-Related Hepatocellular Carcinoma-Authors' Reply
来信:HBV相关肝细胞癌术后复发与病毒复制活性之间关联的研究——作者回复
Alimentary pharmacology & therapeutics. 2025 Apr 25.
-
The EZ-ALBI and PALBI scores contribute to the clinical application of ALBI in predicting postoperative recurrence of HCC
EZ-ALBI和PALBI评分促进ALBI在预测肝细胞癌术后复发中的临床应用
Scientific reports. 2025 Mar 17;15(1):9132.
-
[The influence of HBsAg expression in liver tissue on the postoperative recurrence of HCC patients]
肝组织HBsAg表达对乙肝相关性肝癌患者术后复发的影响分析
Zhonghua zhong liu za zhi [Chinese journal of oncology]. 2022 Apr 23;44(4):347-353.
-
Denoised recurrence label-based deep learning for prediction of postoperative recurrence risk and sorafenib response in HCC
基于去噪复发标签的深度学习在肝细胞癌术后预测复发风险和索拉非尼反应中的应用
BMC medicine. 2025 Mar 18;23(1):162.
-
Prediction of Postoperative Recurrence in Crohn's Disease: Where Do We Go From Here?
克罗恩病术后复发的预测:未来何去何从?
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2023 Nov;21(12):3017-3018.
-
Impact of MAFLD criteria on postoperative recurrence of non-B, non-C HCC
MAFLD诊断标准对非乙型肝炎、非丙型肝炎HCC术后复发的影响
European journal of gastroenterology & hepatology. 2024 Apr 1;36(4):430-437.